BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31051232)

  • 1. Design and development of letrozole nanoemulsion: A comparative evaluation of brain targeted nanoemulsion with free letrozole against status epilepticus and neurodegeneration in mice.
    Iqbal R; Ahmed S; Jain GK; Vohora D
    Int J Pharm; 2019 Jun; 565():20-32. PubMed ID: 31051232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase inhibition by letrozole attenuates kainic acid-induced seizures but not neurotoxicity in mice.
    Iqbal R; Jain GK; Siraj F; Vohora D
    Epilepsy Res; 2018 Jul; 143():60-69. PubMed ID: 29665500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol.
    Reddy DS
    Neuroscience; 2004; 129(1):195-207. PubMed ID: 15489042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced estradiol synthesis by letrozole, an aromatase inhibitor, is protective against development of pentylenetetrazole-induced kindling in mice.
    Rashid D; Panda BP; Vohora D
    Neurochem Int; 2015 Nov; 90():271-4. PubMed ID: 26449311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ultrasonication techniques on the preparation of novel Amiloride-nanoemulsion used for intranasal delivery in the treatment of epilepsy.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S192-S207. PubMed ID: 30032652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting transdermal delivery of atorvastatin calcium via o/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation.
    Shaker DS; Ishak RAH; Elhuoni MA; Ghoneim AM
    Int J Pharm; 2020 Mar; 578():119073. PubMed ID: 31982556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency.
    Boche M; Pokharkar V
    AAPS PharmSciTech; 2017 Apr; 18(3):686-696. PubMed ID: 27207184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization,
    Ahmed B; Rizwanullah M; Mir SR; Akhtar MS; Amin S
    Biomed Mater; 2022 Sep; 17(6):. PubMed ID: 36108625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.
    Jiang Y; Liu C; Zhai W; Zhuang N; Han T; Ding Z
    Int J Nanomedicine; 2019; 14():9217-9234. PubMed ID: 31819426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis.
    Mohamad SA; Safwat MA; Elrehany M; Maher SA; Badawi AM; Mansour HF
    Drug Deliv; 2021 Dec; 28(1):229-239. PubMed ID: 33501873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress.
    Pangeni R; Sharma S; Mustafa G; Ali J; Baboota S
    Nanotechnology; 2014 Dec; 25(48):485102. PubMed ID: 25392203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation.
    Pandey YR; Kumar S; Gupta BK; Ali J; Baboota S
    Nanotechnology; 2016 Jan; 27(2):025102. PubMed ID: 26629830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies.
    Nour SA; Abdelmalak NS; Naguib MJ; Rashed HM; Ibrahim AB
    Drug Deliv; 2016 Nov; 23(9):3681-3695. PubMed ID: 27648847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect.
    Ashhar MU; Kumar S; Ali J; Baboota S
    Chem Phys Lipids; 2021 Mar; 235():105035. PubMed ID: 33400967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies.
    Parikh RH; Patel RJ
    Curr Drug Deliv; 2016; 13(7):1130-1143. PubMed ID: 26638977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro.
    Colombo M; Figueiró F; de Fraga Dias A; Teixeira HF; Battastini AMO; Koester LS
    Int J Pharm; 2018 May; 543(1-2):214-223. PubMed ID: 29605695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting.
    Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H
    Int J Pharm; 2020 Aug; 586():119499. PubMed ID: 32505580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute inhibition of neurosteroid estrogen synthesis suppresses status epilepticus in an animal model.
    Sato SM; Woolley CS
    Elife; 2016 Apr; 5():. PubMed ID: 27083045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication, Characterization, In vitro Evaluation of Solid Lipid Nanoemulsion of Flunarizine dihydrochloride for Nasal Delivery.
    Newton MJ; Harjot K
    Antiinflamm Antiallergy Agents Med Chem; 2017; 15(3):204-220. PubMed ID: 27993106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.